The legislation will advance groundbreaking medical innovation and research that will help millions of Americans with life-threatening diseases.
BPC applauds FDA’s efforts to incorporate enhancements to accelerate the development and delivery of safe and effective treatments and cures to patients.
Through its extensive research with experts and practitioners, BPC identified numerous benefits for using real-world evidence to modernize drug development.
The Senate HELP Committee held its third markup of legislation that will improve the development process and increase investment in drugs that address health needs.
The REGROW Act—which aligns with recommendations included in a recent BPC report—modernizes FDA’s current regulatory approach toward safe and effective cell therapies.
To keep the United States at the forefront of medical innovation, federal policies need to incentivize new technologies to treat and cure patients.